Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature

BACKGROUND: More than half of patients with colorectal cancer will develop metastatic disease either evident at the time of initial diagnosis or during their course of disease. Besides multidisciplinary management further treatment intensification is warranted to improve the still limited prognosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Alexander, Glockzin, Gabriel, Wienke, Andreas, Arnold, Dirk, Edelmann, Thomas, Hildebrandt, Bert, Hollerbach, Stephan, Illerhaus, Gerald, Königsrainer, Alfred, Richter, Michael, Schlitt, Hans J, Schmoll, Hans-Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503684/
https://www.ncbi.nlm.nih.gov/pubmed/22897915
http://dx.doi.org/10.1186/1471-2407-12-356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503684/
https://www.ncbi.nlm.nih.gov/pubmed/22897915
http://dx.doi.org/10.1186/1471-2407-12-356

Ejemplares similares